23. PTC Learning Objectives

23. PTC Learning Objectives

"Has this visit been worth my time?"

This post-transplant cancer educational resource has several measurable goals for the viewer. Look carefully at the following list and see if you have met those objectives . . .

The successful recipient viewer should progress through the following steps -

1st, recognition and acceptance of the higher PTC risk facts, followed . . .

2nd, by learning how to recognize symptoms, then . . .

3rd, looking for those symptoms and . . . 

4th, taking actions based on learned best practices and self-exam findings to prevent, diagnose and treat PTC with support of their medical teams

Note: In each objective listed below, they are meant to be 'measurable objectices' - we plan to add self-testing resources for each to provide that measurement of success in a future update - stay tuned.

computer 3343887 1280


The specific learning objectives are:

Objective #1: organ recipients will understand and acknowledge their increased risk over time of cancer post-transplant. Specifically understanding which cancers present a higher risk based on their organ transplant type.
     How will this be measured?
          • Via multiple-choice survey question contrasting non-transplant population vs. transplant population

Objective #2: organ recipients will learn and apply PTC best practices using a written set of goals personalized from these best practices designed to prevent and diagnose common types of post-transplant cancers.
     How will this be measured?
          • By quiz based on best practice actions. By solicitation/reminder of goal statements.

Objective #3: organ recipients will learn to recognize symptoms of common post-transplant cancers
     How will this be measured?
          • By a matching exercise between names of cancer and common symptoms. For example,
            pictures of skin cancers, as one example – see: https://www.aad.org/public/spot-skin-cancer/learn-about-skin-cancer/spot-skin-cancer-quiz)

Objective #4: organ recipients will carefully, regularly self-examine/self-assess symptoms for signs of cancer, proactively following up on any suspicious symptoms with their medical teams.
     How will this be measured?
          • By survey quiz showing examples of self-exams/self-assessment recommendations (for non-visible cancers).
            Periodic reminder surveys that call for confirming responses when action is taken.

Objective #5: organ recipients will take actions to engage medical professionals in periodic screenings for post-transplant cancers appropriate to their type of transplant, age, length of time from transplant and personal/family history of cancer.
     How will this be measured?
          • By periodic reminder surveys that call for confirming responses when action is taken.

Objective #6: organ recipients will ensure that exams and diagnosis concerns are not dismissed in being overly simplified, rather handled by organ transplant specialists familiar with the higher risk of cancer for transplant recipients.
     How will this be measured?
          • Using recipient/doctor scenarios to select appropriate levels of concern/treatment from stories
            demonstrating suitable and unsuitable treatment of concerns.


Choose a resource for more information:

Sponsors & Supporters

  • Gift of Life Donor Program
  • CareDx
  • Atara Bio
  • GuideStar 2020 Platinum
  • UNOS
  • AAKP
  • Clinical Consulting Associates
  • GLI
  • Notion design sponsor
  • solicitation
    Follow TRIO on  

    DISCLAIMER: The content of this TRIO post-transplant cancer Web site is not influenced by sponsors. The site is designed primarily for use by transplant recipients and their supporters. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with your transplant team or a physician skilled in cancer and your organ type if you suspect you are ill.